3.99 USD
▼-0.03-0.75%
盘后 3.68 0.00%
2026-09-16
市值
$49.60M
市盈率
—
EPS
-3.50
股息率
—
52 周区间
3.25 – 13.50
成交量
225.72K
Beta
0.95
目标价
32.20
52W 低 3.2552W 高 13.50
价格走势
公司简介
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company’s lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinde...